Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to CTMX Stock Lookup

CytomX Therapeutics (CTMX) – PRNewswire

Nov 17, 2022 07:00 AM Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer

Back to CTMX Stock Lookup